ATE476528T1 - Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus - Google Patents

Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus

Info

Publication number
ATE476528T1
ATE476528T1 AT05853253T AT05853253T ATE476528T1 AT E476528 T1 ATE476528 T1 AT E476528T1 AT 05853253 T AT05853253 T AT 05853253T AT 05853253 T AT05853253 T AT 05853253T AT E476528 T1 ATE476528 T1 AT E476528T1
Authority
AT
Austria
Prior art keywords
nucleic acid
different types
human papillomavirus
acid detection
hpv
Prior art date
Application number
AT05853253T
Other languages
English (en)
Inventor
Neeraj Rao
Sylvia A Norman
Jennifer J Bungo
William L Hanna
Original Assignee
Gen Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Probe Inc filed Critical Gen Probe Inc
Application granted granted Critical
Publication of ATE476528T1 publication Critical patent/ATE476528T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT05853253T 2004-12-08 2005-12-08 Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus ATE476528T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63445804P 2004-12-08 2004-12-08
PCT/US2005/044291 WO2006063065A2 (en) 2004-12-08 2005-12-08 Detection of nucleic acids from multiple types of human papillomaviruses

Publications (1)

Publication Number Publication Date
ATE476528T1 true ATE476528T1 (de) 2010-08-15

Family

ID=36578528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05853253T ATE476528T1 (de) 2004-12-08 2005-12-08 Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus

Country Status (8)

Country Link
US (19) US7354719B2 (de)
EP (1) EP1819835B1 (de)
JP (9) JP5020825B2 (de)
AT (1) ATE476528T1 (de)
AU (3) AU2005314061B2 (de)
CA (1) CA2588581C (de)
DE (1) DE602005022759D1 (de)
WO (1) WO2006063065A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000500342A (ja) * 1995-11-15 2000-01-18 ジェン−プローブ・インコーポレーテッド ヒトパピローマウイルス核酸に相補的な核酸プローブおよび関連する方法およびキット
EP1819835B1 (de) 2004-12-08 2010-08-04 Gen-Probe Incorporated Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US20100003704A1 (en) * 2008-06-13 2010-01-07 Shuling Cheng IN SITU detection of early stages and late stages HPV infection
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
EP1997914A1 (de) * 2007-06-01 2008-12-03 Università Degli Studi Di Milano - Bicocca Identifizierung und Quantifizierung onkogener HPV-Nukleinsäuren mittels PCR-Assays in Echtzeit
JP5313157B2 (ja) * 2007-10-19 2013-10-09 栄研化学株式会社 核酸増幅法、それに用いる試薬及び試薬キット
JP5595276B2 (ja) * 2007-11-01 2014-09-24 フェレニヒン フォール クリステレイク ホーヘル オンデルウェイス，ウェーテンスハッペレイク オンデルズーク エン パティエンテンゾルフ 子宮頸部ｈｐｖの新たな検出方法
EP2358910B1 (de) * 2008-11-19 2017-11-22 DiagCor Life Science Limited Nukleotidsequenzen, verfahren und kits für den nachweis von hpv
EP2401287B3 (de) 2009-02-26 2018-09-26 Gen-Probe Incorporated Assay zum nachweisen menschlicher parvoviren-nukleinsäure
EP2427763A4 (de) 2009-05-07 2013-08-21 Oncohealth Corp Identifikation eines hohen cin2-grades zur erkennung von früh- und spätstadien sowie zum screening und zur diagnose des menschlichen papillomavirus (hpv) und mit diesem assoziierter krebserkrankungen
JP5819851B2 (ja) 2010-01-08 2015-11-24 オンコヘルス コーポレーション Ｈｐｖ関連の癌の治療及びスクリーニングのための細胞に基づいた高処理能力ｈｐｖ免疫アッセイ
US9410189B2 (en) * 2010-04-30 2016-08-09 Co-Diagnostics, Inc. Methods of preventing non-specific reactions of nucleotide sequences
JP6153866B2 (ja) 2010-05-25 2017-06-28 キアゲン ガイサーズバーグ アイエヌシー． 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ
EP2455658B1 (de) 2010-11-17 2016-03-02 Orcan Energy AG Verfahren und Vorrichtung zur Verdampfung organischer Arbeitsmedien
AU2013205122B2 (en) * 2012-10-11 2016-11-10 Gen-Probe Incorporated Compositions and Methods for Detecting Human Papillomavirus Nucleic Acid
CN103409560A (zh) * 2013-08-19 2013-11-27 潘晓静 一种广谱、高效、经济的高危人乳头状瘤病毒的pcr检测方法
EP3348634B1 (de) * 2015-09-10 2023-08-09 Kaneka Corporation Verfahren zur trennung von nukleinsäuren aus einer probe mit nukleinsäure und vorrichtung dafür
WO2019099629A1 (en) * 2017-11-17 2019-05-23 Gen-Probe Incorporated COMPOSITIONS AND METHODS FOR DETECTING C1orf43 NUCLEIC ACID
US12059675B2 (en) 2019-11-26 2024-08-13 Yokogawa Electric Corporation Tip device, tip container set, tip electrode apparatus, and tip electrode set
CA3175312A1 (en) * 2020-03-16 2021-09-23 The University Of North Carolina At Chapel Hill Compositions and methods for the selective detection of tumor-derived viral dna
CN114020363B (zh) * 2021-11-15 2023-12-15 海能达通信股份有限公司 群组附着方法及相应设备
WO2024081776A1 (en) * 2022-10-13 2024-04-18 Gen-Probe Incorporated Cellularity control for nucleic acid assays

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876922A (en) * 1985-07-31 1999-03-02 Institute Pasteur Papillomavirus probe and a process for in vitro diagnosis of papillomavirus infections
US5411857A (en) * 1985-07-31 1995-05-02 Institut Nationale De La Sante Probes for papillomaviruses and an in vitro diagnostic procedure for papilloma infections
CA1276575C (fr) * 1984-11-30 1990-11-20 Sylvie Beaudenon Sondes a papillomavirus et procede de diagnostic in vitro d'infections a papillomavirus
DE3779175D1 (de) * 1986-03-21 1992-06-25 Pasteur Institut Bestimmte, von einem papillomavirus-genom abgeleitete dns-sequenzen, deren anwendungen fuer in vitro-diagnostische zwecke und die herstellung von antigenzusammensetzungen.
JP3096704B2 (ja) * 1987-02-26 2000-10-10 バイオサーチ インターナショナル ピティ リミテッド ヒトの発癌性乳頭腫ウイルスの検出方法
US4849332A (en) * 1987-05-26 1989-07-18 Life Technologies, Inc. Human papillomavirus 35 nucleic acid hybridization probes and methods for employing the same
US4849334A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 43 nucleic acid hybridization probes and methods for employing the same
US4849331A (en) * 1987-06-09 1989-07-18 Life Technologies, Inc. Human papillomavirus 44 nucleic acid hybridization probes and methods for employing the same
US4908306A (en) * 1987-06-12 1990-03-13 Life Technologies, Inc. Human papillomavirus 56 nucleic acid hybridization probes and methods for employing the same
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
AU2785589A (en) * 1987-10-02 1989-04-18 Microprobe Corporation Human papillomavirus type diagnosis with nucleotide probes
US5030557A (en) * 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
FR2627590A1 (fr) 1988-02-24 1989-08-25 Ire Celltarg Sa Sonde d'acides nucleiques comportant un nucleotide terminal modifie chimiquement en 5(prime) (oh) en vue de son marquage non radioactif et procedes de preparation
FR2632956B2 (fr) * 1988-05-13 1991-07-12 Pasteur Institut Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55; produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55; procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
CA1339729C (en) * 1988-10-26 1998-03-17 Wayne D. Lancaster Human papillomavirus type 52 dna sequences and methods for employing thesame
DE3838269A1 (de) * 1988-11-11 1990-05-17 Behringwerke Ag Nachweis humaner papillomavirus dna und ihrer expression in zervix-abstrichen
JP2791685B2 (ja) 1989-06-08 1998-08-27 寳酒造株式会社 パピローマウイルスの検出方法
EP0502994B1 (de) * 1989-12-01 1995-09-06 Amoco Corporation Detektion von hpv-transkripts
US5580970A (en) * 1989-12-01 1996-12-03 Amoco Corporation Detection of HPV transcripts
US5695926A (en) * 1990-06-11 1997-12-09 Bio Merieux Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support
JP2785164B2 (ja) 1990-08-20 1998-08-13 寳酒造株式会社 ヒトパピローマウイルスの検出方法
US5484699A (en) * 1990-09-28 1996-01-16 Abbott Laboratories Nucleotide sequences useful as type specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
FR2670797A1 (fr) * 1990-12-20 1992-06-26 Pasteur Institut Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
FR2678284B1 (fr) * 1991-06-28 1993-10-08 Pasteur Institut Sequences d'adn derivees du genome du papillomavirus hpv42, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus et a la production de compositions immunogenes.
ZA929351B (en) * 1991-12-11 1993-06-04 Igen Inc Electrochemiluminescent label for DNA assays.
EP1288296A3 (de) 1992-05-11 2003-03-12 Ribozyme Pharmaceuticals, Inc. Verfahren und Reagenz zur Hemmung der HBV viralen Replikation
ZA936016B (en) * 1992-08-24 1994-03-10 Akzo Nv Method for nucleic acid amplification
US5618536A (en) 1992-09-03 1997-04-08 The United States Of America As Represented By The Department Of Health And Human Services Chimeric papillomavirus-like particles
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
CA2139623A1 (en) 1993-05-06 1994-11-24 Baxter Diagnostics Inc. Human papillomavirus detection assay
US6174668B1 (en) * 1993-05-14 2001-01-16 Johnson & Johnson Clinical Diagnostics, Inc. Diagnostic compositions, elements, methods and test kits for amplification and detection of two or more target DNA's using primers having matched melting temperatures
US5679509A (en) * 1993-09-28 1997-10-21 University Of New Mexico Methods and a diagnostic aid for distinguishing a subset of HPV that is associated with an increased risk of developing cervical dysplasia and cervical cancer
AUPM566794A0 (en) * 1994-05-17 1994-06-09 University Of Queensland, The Process and product
NZ293461A (en) * 1994-09-22 1998-04-27 Merck & Co Inc Dna encoding human papillomavirus type 6a, compounds derived therefrom
AUPN015794A0 (en) * 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
DE19506561C1 (de) * 1995-02-24 1996-10-10 Deutsches Krebsforsch Verfahren zur Früherkennung von HPV-assoziierten Karzinomen bzw. von hochgradigen, durch HPV-verursachten Dysplasien
US5840306A (en) * 1995-03-22 1998-11-24 Merck & Co., Inc. DNA encoding human papillomavirus type 18
IL117591A0 (en) * 1995-03-30 1996-07-23 Merck & Co Inc Synthetic DNA encoding human papillomavirus type 11 L1 protein
JP2000500342A (ja) * 1995-11-15 2000-01-18 ジェン−プローブ・インコーポレーテッド ヒトパピローマウイルス核酸に相補的な核酸プローブおよび関連する方法およびキット
US5981173A (en) 1996-02-14 1999-11-09 Institut Pasteur Genital human papillomavirus type 68a (HPV-68a), related to the potentially oncogenic HPV-39
WO1997039010A1 (en) * 1996-04-15 1997-10-23 The University Of New Mexico Probes for the detection of human papillomavirus
US6228368B1 (en) * 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use
US6013258A (en) * 1997-10-09 2000-01-11 Zycos Inc. Immunogenic peptides from the HPV E7 protein
US5932451A (en) * 1997-11-19 1999-08-03 Incyte Pharmaceuticals, Inc. Method for unbiased mRNA amplification
DK1038022T3 (da) * 1997-12-12 2005-10-24 Digene Corp Evaluering af humane papillomavirus-tilknyttede sygdomme
CA2229955C (en) 1998-02-20 2003-12-09 Medigene Gmbh Papilloma virus capsomere vaccine formulations and methods of use
US7494658B2 (en) 1998-02-20 2009-02-24 Medigene Ag Papilloma virus truncated L1 protein and fusion protein constructs
AU766403C (en) * 1998-09-04 2004-05-27 Aventis Pasteur Limited Treatment of cervical cancer
US6313373B1 (en) * 1998-10-30 2001-11-06 Case Western Reserve University Tissue specific promoters and transgenic mouse for the screening of pharmaceuticals
EP1006199A1 (de) * 1998-12-03 2000-06-07 Kreatech Biotechnology B.V. Verfahren zur Herstellung von Verknüpfungen an ausgewählten Positionen von Nukleinsäuresträngen und deren Verwendung
SE515668C2 (sv) 1999-02-22 2001-09-17 Quantovir Ab Metod och kit för tidig förutsägelse av cancer
FR2794370B1 (fr) * 1999-06-03 2003-10-17 Biovector Therapeutics Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
ATE456677T1 (de) * 1999-07-09 2010-02-15 Gen Probe Inc Hiv-1 detektion mittels nukleinsäureamplifizierung
AU784605B2 (en) * 1999-10-20 2006-05-11 Johns Hopkins University School Of Medicine, The Chimeric immunogenic compositions and nucleic acids encoding them
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
WO2001042467A2 (en) * 1999-12-08 2001-06-14 Millennium Pharmaceuticals, Inc. Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
DE10009143B4 (de) * 2000-02-26 2012-04-26 Eberhard-Karls-Universität Tübingen Universitätsklinikum Nachweis von Humanen Papillomviren
US6936443B2 (en) * 2000-04-03 2005-08-30 Cytyc Corporation Detection and typing of human papillomavirus using PNA probes
JP2001321168A (ja) 2000-05-12 2001-11-20 Toshiyuki Sasagawa Ｈｐｖ感染型の同定方法
US7439016B1 (en) * 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
US7601497B2 (en) * 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
GB0018050D0 (en) 2000-07-21 2000-09-13 Norchip As Detection of human papillomavirus mRNA
DE10059630A1 (de) * 2000-12-01 2002-06-06 Medigene Ag Arzneimittel zur Vermeidung oder Behandlung von durch humanen Papillomavirus-Typ 18-hervorgerufenem Tumor
EP1377679B1 (de) * 2000-12-14 2009-10-28 Gen-Probe Incorporated Verfahren und kits zur verbesserung der hybridisierungsraten von polynukleotiden
JP2004533256A (ja) * 2001-06-14 2004-11-04 ユニバーシティ オブ ウェールズ カレッジ オブ メディスン ウイルス検出方法、ウイルス検出用プライマー、及びスクリーニングキット
WO2003014402A2 (en) * 2001-08-08 2003-02-20 Glaxosmithkline Biologicals S.A. Method for identification of type specific polynucleotide sequences
US6884605B2 (en) * 2001-08-09 2005-04-26 Board Of Trustees Of The University Of Arkansas Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer
GB0120938D0 (en) * 2001-08-29 2001-10-17 Norchip As Detection of human papillomavirus E7 mRNA
GB0200258D0 (en) * 2002-01-07 2002-02-20 Norchip As Detection of human papillomavirus
WO2003057914A2 (en) * 2002-01-07 2003-07-17 Norchip A/S METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS mRNA
AU2003270823A1 (en) * 2002-09-19 2004-04-08 Johns Hopkins University School Of Medicine Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
SE0202897D0 (sv) * 2002-10-01 2002-10-01 Quantovir Ab Method and kit for quantitative and qualitative determination of human papillomavirus
WO2004030636A2 (en) * 2002-10-03 2004-04-15 Wyeth Holdings Corporation Human papillomavirus polypeptides and immunogenic compositions
BRPI0414801A (pt) * 2003-09-25 2006-11-14 Third Wave Tech Inc detecção de hpv
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
EP1778867B1 (de) 2004-07-01 2010-04-28 Gen-Probe Incorporated Verfahren und zusammensetzungen zum nachweis von nukleinsäuren in einer biologischen probe
EP1819835B1 (de) * 2004-12-08 2010-08-04 Gen-Probe Incorporated Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
WO2006096224A2 (en) * 2004-12-20 2006-09-14 Cytyc Corporation A method for the simultaneous detection of hpv rna & dna in a sample
US7524631B2 (en) * 2005-02-02 2009-04-28 Patterson Bruce K HPV E6, E7 mRNA assay and methods of use thereof
US20070111960A1 (en) * 2005-03-04 2007-05-17 Advandx, Inc. High affinity probes for analysis of human papillomavirus expression
JP6076679B2 (ja) * 2012-10-15 2017-02-08 ナカ工業株式会社 手摺笠木

Also Published As

Publication number Publication date
US20140038173A1 (en) 2014-02-06
US7682792B2 (en) 2010-03-23
US20130078618A1 (en) 2013-03-28
JP2021176306A (ja) 2021-11-11
JP2019213560A (ja) 2019-12-19
US20150292047A1 (en) 2015-10-15
JP6128705B2 (ja) 2017-05-17
EP1819835A2 (de) 2007-08-22
US20190376152A1 (en) 2019-12-12
CA2588581A1 (en) 2006-06-15
US11613788B2 (en) 2023-03-28
AU2012203392A1 (en) 2012-06-28
US10711317B2 (en) 2020-07-14
US9328392B2 (en) 2016-05-03
JP2017113038A (ja) 2017-06-29
EP1819835A4 (de) 2009-09-02
US8574841B2 (en) 2013-11-05
AU2005314061B2 (en) 2010-01-28
US20150094235A1 (en) 2015-04-02
JP5648016B2 (ja) 2015-01-07
US8835114B2 (en) 2014-09-16
US20200032355A1 (en) 2020-01-30
US11359252B2 (en) 2022-06-14
JP6038067B2 (ja) 2016-12-07
JP2023083425A (ja) 2023-06-15
AU2005314061A1 (en) 2006-06-15
US10047407B2 (en) 2018-08-14
US20140030701A1 (en) 2014-01-30
US20140342351A1 (en) 2014-11-20
US20080311559A1 (en) 2008-12-18
US20150292046A1 (en) 2015-10-15
WO2006063065A2 (en) 2006-06-15
JP6857632B2 (ja) 2021-04-14
US20190002995A1 (en) 2019-01-03
US8026066B2 (en) 2011-09-27
US20210164063A1 (en) 2021-06-03
JP5020825B2 (ja) 2012-09-05
US20200165689A1 (en) 2020-05-28
AU2010201656B2 (en) 2012-03-15
DE602005022759D1 (de) 2010-09-16
US20060121516A1 (en) 2006-06-08
US20110311961A1 (en) 2011-12-22
WO2006063065A3 (en) 2008-07-31
US20100105027A1 (en) 2010-04-29
US10465255B2 (en) 2019-11-05
US20210010095A1 (en) 2021-01-14
EP1819835B1 (de) 2010-08-04
JP6590857B2 (ja) 2019-10-16
US7354719B2 (en) 2008-04-08
JP2016025875A (ja) 2016-02-12
AU2010201656A1 (en) 2010-05-20
US20180002768A1 (en) 2018-01-04
US9765407B2 (en) 2017-09-19
US11624096B2 (en) 2023-04-11
US10640836B2 (en) 2020-05-05
US8828660B2 (en) 2014-09-09
CA2588581C (en) 2011-05-31
JP2008522620A (ja) 2008-07-03
US10968494B2 (en) 2021-04-06
JP2018138061A (ja) 2018-09-06
US8334098B2 (en) 2012-12-18
JP2012165751A (ja) 2012-09-06
US9074263B2 (en) 2015-07-07
US8785125B2 (en) 2014-07-22
US20140024021A1 (en) 2014-01-23
JP2014138615A (ja) 2014-07-31
AU2012203392B2 (en) 2013-09-12

Similar Documents

Publication Publication Date Title
ATE476528T1 (de) Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
EA201170933A1 (ru) Анализ нуклеиновых кислот, полученных из единичных клеток
MX2012002411A (es) Metodos de ensayo para el mdv-1.
EP1578952A4 (de) Direkter snp-nachweis mit nichtamplifizierter dna
EP2471805A3 (de) Zusammensetzungen und Verfahren zur spezifischen Detektion von Nukleinsäuren der Viren Influenza A oder B
DE60120501D1 (de) mRNA AMPLIFIZIERUNG
WO2007021250A3 (en) Method and/or apparatus of oligonucleotide design and/or nucleic acid detection
MX2012001000A (es) Metodo y kit para la deteccion de un microorganismo.
Fozouni et al. Direct detection of SARS-CoV-2 using CRISPR-Cas13a and a mobile phone
EP2504453A4 (de) Assayverfahren für zielnukleinsäuren durch signalverstärkung mit sondenhybridisierung und -beschränkung
NZ594004A (en) Production of closed linear dna
GB2445529A (en) Method for isothermal amplification of nucleic acids and method for detecting nucleic acids using simultaneous isothermal amplification of nucleic acids
DE602004026077D1 (de) Erstellung von expressionsprofilen unter verwendung von mikroarrays
WO2008054834A3 (en) Binary deoxyribozyme probes for nucleic acid analysis
WO2004035765A3 (en) Double-stranded rna structures and constructs, and methods for generating and using the same
WO2007066831A3 (en) Method of detecting human papilloma virus by using nucleic acid amplification method and nucleic acid chain-immobilized carrier
ATE505562T1 (de) Doppel-oligonukleotid- nukleinsäurenachweisverfahren
SG161271A1 (en) Method for the detection and characterization of microorganisms on a filter
NZ601652A (en) Set of probes for the detection and typing of 46 human papillomavirus mucosal types
EP2412830A3 (de) Zusammensetzungen und Verfahren zur Detektion von Hepatitis-A-Virus-Nukleinsäure
EP1988178A3 (de) Nukleotid-Primer-Set und Nukleotidsonde für den Nachweis des Serum-Amyloid A1 (SAA1)-Genotyps
Geraldi et al. Synthetic biology-based portable in vitro diagnostic platforms
RU2014122607A (ru) Способы определения восприимчивости пациента к внутрибольничной инфекции и составления прогноза развития септического синдрома
ATE478158T1 (de) Hybridisierungsverfahren
FR2878254B1 (fr) Composition pour l'amplification d'acides nucleiques

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties